dactinomycin has been researched along with Breast Cancer in 168 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 64 (38.10) | 18.7374 |
| 1990's | 51 (30.36) | 18.2507 |
| 2000's | 35 (20.83) | 29.6817 |
| 2010's | 15 (8.93) | 24.3611 |
| 2020's | 3 (1.79) | 2.80 |
| Authors | Studies |
|---|---|
| Alsherbiny, MA; Bhuyan, DJ; Chang, D; Li, CG; Low, MN | 1 |
| Ancel, J; Birembaut, P; Bourcy, M; Francart, ME; Genna, A; Gilles, C; Lambert, J; Noël, A; Perez-Boza, J; Polette, M; Struman, I; Vanwynsberghe, AM | 1 |
| Lu, S; Qi, L; Sun, B; Yang, B | 1 |
| Banerjee, J; Das, T; Green, R; Howell, M; Mohapatra, S; Mohapatra, SS; Nair, RR; Padhee, S | 1 |
| Aguilar, M; Burgos, PV; Ehrenfeld, P; Luchsinger, C; Mardones, GA | 1 |
| Akbari-Birgani, S; Kaboudin, B; Madadi, Z; Mohseni-Dargah, M; Saghatchi, F | 1 |
| Han, Z; Jia, F; Li, X; Lin, S; Liu, F; Ma, J; Xie, W; Zhang, C | 1 |
| Bendinelli, P; Desiderio, MA; Locatelli, A; Maroni, P; Matteucci, E | 1 |
| Karbwang, J; Ketsa-Ard, K; Na-Bangchang, K; Picha, P; Thisoda, P; Thongprasert, S; Vongsakul, M | 1 |
| Lain, S; Rao, B; Thompson, AM | 1 |
| Larsson, C; Leandersson, K; Winslow, S | 1 |
| Koirala, S; Thomas, LN; Too, CK | 1 |
| Ayas, S; Cetiner, H; Gurbuz, A; Karateke, A | 1 |
| Dougherty, SM; Klinge, CM; Li, Y; Manavalan, TT; Riggs, KA; Wickramasinghe, NS | 1 |
| Montano, X | 1 |
| Athanasiou, A; El Khoury, C; Malhaire, C; Ollivier, L; Petrow, P; Tardivon, A; Thibault, F | 1 |
| Balapure, AK; Gupta, DK; Nigam, D; Nigam, M; Ranjan, V; Sharma, R; Singh, N; Sundaram, S; Zaidi, D | 1 |
| Jefferson, B; Lobert, S; Morris, K | 1 |
| Lui, WY; Wang, Y | 1 |
| El Gendy, MA; El-Kadi, AO; Korashy, HM; Maayah, ZH | 1 |
| Akutsu, H; Kimura, H; Lee, SW; Masui, S; Nagashima, Y; Nishi, M; Perrem, K; Quinn, G; Ryo, A; Sakai, Y; Umezawa, A; Yamamoto, N | 1 |
| Andreocci, L; Battaglia, A; Coscarella, A; Fattorossi, A; Maggiano, N; Malinconico, P; Parente, D; Perillo, A; Pierelli, L; Scambia, G; Stoler, A | 1 |
| Gudas, LJ; Liu, L | 1 |
| Depatie, C; Hayakawa, J; Mercola, D; Ohmichi, M | 1 |
| Alkhalaf, M; El-Mowafy, AM | 1 |
| Bernard-Gallon, DJ; Bignon, YJ; Vissac-Sabatier, C | 1 |
| AKOPYANTS, SS; BELOVA, ZN; EBERT, MK; GOSHEVA, AE; GRACHEVA, NP; KHARITONOVA, AM; PLANELLES, JJ; SILAEV, AB; SOLOVYEVA, YV | 1 |
| FALKSON, G; SNYMAN, HJ | 1 |
| BREUR, K; KROESE, WF | 1 |
| BUSCH, GJ; OWENS, AH | 1 |
| Domann, FE; Duan, H; Futscher, BW; Oberley, LW; Yang, JQ; Zhang, HJ | 1 |
| Amodeo, R; Anghel, G; De Rosa, L; Majolino, I; Pandolfi, A; Riccardi, M | 1 |
| Hsieh, HY; Hsieh, YS; Huang, CY; Kuo, SJ; Liu, JY; Tsai, JH; Wu, TT; Yu, SY | 1 |
| Pawlak, KJ; Wiebe, JP; Zhang, G | 1 |
| Kim, J; Paulson, KE; Rieger-Christ, KM; Summerhayes, IC; Wazer, DE; Yee, AS; Zhang, X | 1 |
| Bass, SE; Ciolino, HP; MacDonald, CJ; Memon, OS; Yeh, GC | 1 |
| Kawakami, M; Kawase, K; Kobayashi, T; Morikawa, T; Nogi, H; Suzuki, M; Tabei, I; Toriumi, Y; Uchida, K | 1 |
| Brce, J; Doyle, N; Ho, KK; Lee, HJ; Leong, GM; Leung, KC; Sjögren, K | 1 |
| Filippova, NA; Klemyashov, IV; Kretushev, AV; Raikhlin, NT; Shtil', AA; Tychinskii, VP; Vyshenskaya, TV | 1 |
| Dudek, AZ; Jasinski, P; Terai, K; Zwolak, P | 1 |
| Harder, M; Limacher, F | 1 |
| Chelidze, PV; Tumanishvili, GD | 1 |
| Huff, KK; Kasid, A; Lippman, ME; Strobl, JS | 1 |
| Abel, U; Becher, R; Edler, L; Fritze, D; Hartlapp, J; Illiger, HJ; Kaufmann, M; Massner, B; Mayr, AC; Queisser, W | 1 |
| Brooks, RJ; Garewal, HS; Giordano, GF; Heusinkveld, RS; Jackson, R; Jones, SE; Kemmer, SR; Ketchel, SJ; Moon, TE; Takasugi, BJ | 1 |
| Dickerman, HW; Kumar, SA; Ryan, TJ; Seeger, JI | 1 |
| Draves, DP; Rose, DP; Ruzicka, FJ | 1 |
| Horwitz, KB; McGuire, WL | 3 |
| Aiginger, P; Horwitz, KB; Kuttenn, F; McGuire, WL | 1 |
| Braun, DW; Donnell, RM; Kaufman, RJ; Kay, S; Kinne, DW; Lieberman, PH; Rosen, PP | 1 |
| Barnes, PL; Cooper, MR; Grimm, RA; Jackson, DV; Muss, HB; Richards, F; Spurr, CL; Stuart, JJ; White, DR | 1 |
| Smith, CD; Zilfou, JT | 1 |
| Sato, H; Seiki, M; Thompson, EW; Yu, M | 1 |
| Barrenetxea, G; Centeno, MM; Pérez, C; Rodríguez-Escudero, FJ; Schneider, J; Tánago, JG | 1 |
| Keski-Oja, J; Koli, K | 1 |
| Furukawa, Y; Hayashi, K; Hirota, M; Miyashita, S; Shiroyama, C; Yamamoto, T | 1 |
| Benz, CC; Garovoy, MR; Hunt, CA; Noonberg, SB; Scott, GK | 1 |
| Beery, R; Geier, A; Haimsohn, M; Hemi, R; Karasik, A; Malik, Z | 1 |
| Davie, JR; Murphy, LC | 1 |
| Gol-Winkler, R; Grooteclaes, M; Pasleau, F | 1 |
| Casazza, AM; Horwitz, SB; Trail, PA; Wang, L; Yang, CP | 1 |
| Furukawa, Y; Hayashi, K; Kida, N; Mori, K; Nagao, S; Nozawa, Y; Takahashi, H; Yoshimura, T | 1 |
| Fujita, S; Inada, K; Matsuo, S; Nakashima, Y; Nomura, K; Ogawa, M; Saishoji, T; Takano, S; Yamashita, J; Yamashita, S | 1 |
| Powles, TJ; Smith, IE | 1 |
| Amley, J; Chan, PK; Koller, CA; Qi, Y | 1 |
| Phang, JM; Sathyamoorthy, N; Wang, TT | 1 |
| Jing, Y; Mira-y-Lopez, R; Waxman, S; Zhang, J | 1 |
| Addeo, R; Altucci, L; Beato, M; Bresciani, F; Cicatiello, L; Dauvois, S; Parker, MG; Sica, V; Truss, M; Weisz, A | 1 |
| Chrysogelos, SA; El-Ashry, D; Lauber, AH; Yarden, RI | 1 |
| Jackson, JG; Lee, AV; Weng, CN; Yee, D | 1 |
| McLaren, AW; Moffat, GJ; Wolf, CR | 1 |
| Liu, J; Spence, MJ; Vestal, RE | 1 |
| Busch, H; Perlaky, L; Valdez, BC | 1 |
| Alvarez, S; Binderup, L; López-Boado, YS; López-Otín, C; Puente, XS; Tolivia, J | 1 |
| Dante, R; Frappart, L; Leclerc, D; Lenoir, G; Magdinier, F; Ribieras, S | 1 |
| Linder, S; Ljungdahl, S; Shoshan, MC; Swedenborg, J; Zhou, JN | 1 |
| Aaronson, SA; Arizti, P; Kurdistani, SK; Lee, SW; Reimer, CL; Sugrue, MM | 1 |
| El Khissiin, A; Laios, I; Larsimont, D; Leclercq, G; Legros, N; Querton, G; Seo, HS | 1 |
| Lu, R; Serrero, G | 1 |
| Furuya, Y; Hamaoka, T; Kohno, N; Kuroda, Y; Ono, H; Yamamoto, K | 1 |
| Pethe, V; Shekhar, PV | 1 |
| Heyns, W; Swinnen, JV; Ulrix, W; Verhoeven, G | 1 |
| Eleftheriou, A; Henderson, BR | 1 |
| Liu, W; Vadgama, JV | 1 |
| Dipple, A; Khan, QA | 1 |
| Dong, HY; Hashimoto, S; Inadera, H; Matsushima, K; Nagai, S; Suzuki, T; Toyoda, N; Yamashita, T | 1 |
| Creminon, C; Hla, T; Huang, CK; Jang, BC; Liu, CH; Sanchez, T; Schaefers, HJ; Trifan, OC | 1 |
| Fahrenkrug, J; Georg, B; Madsen, B; Madsen, MW | 1 |
| Chiappetta, C; Hyder, SM; Stancel, GM | 1 |
| Sampath, D; Winneker, RC; Zhang, Z | 1 |
| Kumar, P; Lahooti, H; Mark, PJ; Minchin, RF; Ratajczak, T; Ward, BK | 1 |
| Atsumi, GI; Chilton, FH; Clay, CE; High, KP | 1 |
| Clarke, M; Gatzemeier, W; Rauschecker, H; Recht, A | 1 |
| Bowen, WD; Crawford, KW | 1 |
| Labrie, C; Pouliot, F | 1 |
| Anderson, LM; Dipple, A; Khan, QA | 1 |
| Dorssers, LC; Foekens, JA; Klijn, JG; Martens, JW; Sieuwerts, AM | 1 |
| Orlowski, RZ; Shi, YY; Small, GW | 1 |
| Algarra, I; Gaforio, JJ; Jaén, A; Lozano, A; Sánchez-Rovira, P; Serrano, MJ | 1 |
| Hinderer, H; Kaufmann, M; Mattern, J; Volm, M; Wayss, K | 1 |
| Brucksch, KP; Schmidt, CG; Seeber, B; Seeber, S | 1 |
| Ansfield, FJ; Davis, HL; Olson, CE; Ramirez, G; Richards, MJ | 1 |
| Tanneberger, S | 1 |
| Lippman, ME; Monaco, ME | 1 |
| Baumgartner, G | 1 |
| Bolan, G; Lippman, ME; Monaco, ME; Osborne, CK | 1 |
| Pattillo, RA | 1 |
| Benjamin, RS; Blumenschein, GR; Burgess, MA; Gottlieb, JA; Hall, SW; Murphy, WK; Wheeler, WL | 1 |
| Chen, JC; Clemmons, DR; Fontana, JA; LeRoith, D; Roberts, CT; Shao, ZM; Sheikh, MS | 1 |
| Keyomarsi, K; Lee, SW; Paul, D; Sager, R; Tomasetto, C | 1 |
| Hug, V; Levy, JR | 1 |
| Eskild, W; Hansson, V; Knutsen, HK; Landmark, BF; Ree, AH | 1 |
| Adams, JB; Phillips, N; Vrahimis, R | 1 |
| Altermatt, HJ; Brunner, KW; Buser, K; Cerny, T; Fravi, R; Ohnacker, H; Oppikofer, C; Ridolfi Lüthy, A | 1 |
| Cold, S; Pfeiffer, P; Rose, C | 1 |
| de Fazio, A; Kelly, PA; Ormandy, CJ; Sutherland, RL | 1 |
| Gaĭseniuk, LA; Kalmykova, IIa; Kozyreva, TV; Nikiforova, NA; Skobel'tsyna, ES | 1 |
| Ashley, SE; Hardy, JR; Jones, AL; Judson, IR; Powles, TJ | 1 |
| Hamburger, AW; Pinnamaneni, GD | 1 |
| Chu, F; Kaufman, R; Kaufmann, T | 1 |
| Arnold, ST; Felsted, RL; Politi, PM; Sinha, BK | 1 |
| Bircher, JA; Hathaway, LD; Moore, MR | 1 |
| Klefström, P; Nuortio, L | 1 |
| Gyling, M; Heuson, JC; Leclercq, G | 1 |
| Henle, KJ; Monson, TP; Stone, A | 1 |
| Albain, KS; Le Beau, MM; Schumacher, H; Ullirsch, R | 1 |
| Beattie, M; Kingston, JE; Malpas, JS; Norton, AJ | 1 |
| Abe, M; Kufe, D | 1 |
| Danguy, A; Devleeschouwer, N; Leclercq, G; Verrijdt, A | 1 |
| Asoh, K; Kohno, K; Kuwano, M; Mawatari, M; Mizoguchi, H; Ono, M; Watanabe, Y | 1 |
| Alexander, IE; Clarke, CL; Shine, J; Sutherland, RL | 1 |
| Hayashi, K; Kida, N; Mori, K; Yoshimura, T | 1 |
| Schoen, HD; Wendt, T | 1 |
| Degani, H; Neeman, M | 1 |
| Akman, SA; Chu, FF; Doroshow, JH; Forrest, G | 1 |
| Abel, U; Edler, L; Fritze, D; Kaufmann, M; Massner, B; Queisser, W; Schmid, H; Schmidt, R; Westerhausen, M | 1 |
| Emrich, D; Luig, H; Nagel, GA; Wander, HE | 1 |
| Eisman, JA; Frampton, RJ; Sher, E | 1 |
| Baldi, A; Crespi, MD; Genovese, J; Ivanier, SE | 1 |
| Baglioni, C; Latham, K; Ruggiero, V | 1 |
| Dubik, D; Shiu, RP | 1 |
| Bradley, S; Cooke, TG; De Sousa, BA; George, WD; Holt, S; Leinster, SJ | 1 |
| Ahmann, FR; Jones, SE; Moon, TE | 1 |
| Abe, H; Ishida, M; Iwasaki, T; Kaizuka, H; Mori, S; Satodate, R; Tamura, G | 1 |
| Biffl, G; Jordis-Lohausen, K; Lehnert, M; Wählby, S; Wascher, H | 1 |
| Binsack, T; Sauer, H; Wilmanns, W | 1 |
| Wascher, H | 1 |
| Hanauske, AR; Von Hoff, DD | 1 |
| Aitken, SC; Kasid, A; Lippman, ME; Schoenberg, DR | 1 |
| D'Angio, GJ; Tefft, M | 1 |
| Schmidt, CG | 1 |
| Dargent, M; Mayer, M | 1 |
| Jakoubková, J; Májský, A | 1 |
| Friedman, RM; Johnson, GS; Pastan, I | 1 |
| Eylan, E; Gazith, A; Izsak, FC; Naharin, S; Raanani, C; Shapiro, J | 1 |
| Goldenson, Y; Lev, L; Robinson, E | 1 |
| Melchionne, S; Van Duuren, BL | 1 |
| Johnston, GS; Jones, AE | 1 |
| Kagan, AR | 1 |
| Goldie, JH; Price, LA | 1 |
| Abrahámová, J; Havránková, N; Jakoubková, J | 1 |
| Al-Sarraf, M; Sardesai, S; Vaitkevicius, VK; Wong, P | 1 |
| Heinemann, HO; Muggia, FM | 1 |
| Talley, RW | 1 |
| Fischer, DS | 1 |
| Bottomley, RH; Chanes, RE; Condit, PT; Nisimblat, W | 1 |
13 review(s) available for dactinomycin and Breast Cancer
| Article | Year |
|---|---|
p53-Based cyclotherapy: exploiting the 'guardian of the genome' to protect normal cells from cytotoxic therapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Growth Processes; Cell Line, Tumor; Dactinomycin; Female; Genome; Humans; Imidazoles; Phosphorylation; Piperazines; Tumor Suppressor Protein p53 | 2013 |
[Ultrastructure and functions of ring-shaped nucleoli, fibrillar centers and nucleolar vacuoles].
Topics: Animals; Blood Cells; Breast Neoplasms; Cell Differentiation; Cell Division; Cell Nucleolus; Cells, Cultured; Chick Embryo; Dactinomycin; DNA Replication; Female; Humans; Liver; Liver Regeneration; Microscopy, Electron; Nucleolus Organizer Region; Rats; RNA | 1983 |
Studies on mechanisms of estrogen and antiestrogen action in human breast cancer.
Topics: Breast Neoplasms; Cell Line; Cell Nucleus; Cytoplasm; Dactinomycin; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogens; Female; Humans; Nafoxidine; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1980 |
Systemic therapy for treating locoregional recurrence in women with breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Combined Modality Therapy; Dactinomycin; Female; Humans; Interferon-alpha; Neoplasm Recurrence, Local; Randomized Controlled Trials as Topic; Tamoxifen | 2001 |
Individual cell biology: basis and prospects for a rational cancer chemotherapy.
Topics: Adenocarcinoma; Brain Neoplasms; Breast Neoplasms; Cell Cycle; Chromosome Aberrations; Cyclophosphamide; Dactinomycin; DNA, Neoplasm; Drug Resistance; Drug Therapy, Combination; Female; Fluorouracil; Fructose-Bisphosphate Aldolase; Humans; Isoenzymes; Kinetics; Male; Methotrexate; Neoplasm Staging; Neoplasms; Prognosis | 1977 |
Cytotoxic treatment of metastatic breast cancer. Which drugs and drug combinations to use?
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Melphalan; Methotrexate; Mitomycin; Mitoxantrone; Neoplasm Metastasis; Vincristine | 1992 |
Implication of prior treatment with drug combinations including inhibitors of topoisomerase II in therapy-related monocytic leukemia with a 9;11 translocation.
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 9; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Iatrogenic Disease; Leukemia, Monocytic, Acute; Mastectomy, Radical; Middle Aged; Podophyllotoxin; Radiotherapy; Tamoxifen; Topoisomerase II Inhibitors; Translocation, Genetic | 1990 |
Clinical correlations with the human tumor cloning assay.
Topics: Aminoacridines; Amsacrine; Anthracenes; Breast Neoplasms; Clinical Trials as Topic; Clone Cells; Culture Techniques; Dactinomycin; Drug Resistance; Female; Head and Neck Neoplasms; Humans; Interferon Type I; Leukemia; Lung Neoplasms; Melanoma; Multiple Myeloma; Neoplasms; Ovarian Neoplasms; Prospective Studies; Retrospective Studies; Tumor Stem Cell Assay | 1985 |
The role of radiation therapists in oncology.
Topics: Breast Neoplasms; Dactinomycin; Female; Hodgkin Disease; Humans; Laryngeal Neoplasms; Methods; Neoplasms; Palliative Care; Patient Care Team; Preoperative Care; Radiotherapy; Radiotherapy, High-Energy; Skin Neoplasms; Tongue Neoplasms; Uterine Cervical Neoplasms; Workforce | 1971 |
[Cytostatic antibiotics].
Topics: Adult; Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma, Bronchogenic; Dactinomycin; Female; Humans; Male; Mitomycins; Smoking | 1963 |
[Combination chemotherapy in the treatment of cancer].
Topics: Administration, Oral; Antineoplastic Agents; Breast Neoplasms; Chlorambucil; Cyclophosphamide; Dactinomycin; Drug Synergism; Female; Hodgkin Disease; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Methotrexate; Neoplasms; Nitrogen Mustard Compounds; Ovarian Neoplasms; Procarbazine; Testicular Neoplasms; Thiotepa; Vincristine | 1972 |
Inhibition of tumorigenesis.
Topics: Animals; Breast Neoplasms; Carcinogens; Chemical Phenomena; Chemistry; Dactinomycin; DNA, Neoplasm; Enzyme Induction; Isonicotinic Acids; Liver Neoplasms; Mammary Glands, Animal; Mice; Microsomes; Mustard Compounds; Neoplasms, Experimental; Progesterone; Quinolines; Rats; RNA, Neoplasm; Skin Neoplasms | 1969 |
The use of drugs in various types of cancer. 1.
Topics: Allopurinol; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Squamous Cell; Colonic Neoplasms; Cyclophosphamide; Dactinomycin; Diethylstilbestrol | 1970 |
9 trial(s) available for dactinomycin and Breast Cancer
| Article | Year |
|---|---|
Combination chemotherapy (VAC/FMC) with immunostimulation in metastatic breast cancer: a randomized study comparing different times and routes of administration of Corynebacterium parvum.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Female; Fluorouracil; Humans; Immunotherapy; Injections, Intravenous; Injections, Subcutaneous; Mastectomy; Methotrexate; Prognosis; Propionibacterium acnes; Vaccines; Vincristine | 1984 |
Current results of the University of Arizona Adjuvant Breast Cancer trials (1974-1984).
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Fluorouracil; Humans; Lymphatic Metastasis; Male; Mastectomy; Methotrexate; Mitomycins; Neoplasm Staging; Prognosis; Vinblastine; Vincristine | 1984 |
MMM (mitomycin/mitoxantrone/methotrexate): an effective new regimen in the treatment of metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Dactinomycin; Female; Fluorouracil; Humans; Melphalan; Menopause; Methotrexate; Middle Aged; Mitomycin; Neoplasm Metastasis; Neoplasm Staging; Vincristine | 1993 |
Review of local soft tissue recurrence of breast cancer irradiated with and without actinomycin-D.
Topics: Breast Neoplasms; Clinical Trials as Topic; Dactinomycin; Female; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Radiotherapy Dosage; Remission, Spontaneous; Retrospective Studies; Soft Tissue Neoplasms | 1977 |
A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dactinomycin; Female; Humans; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Mitoxantrone; Vincristine | 1991 |
Levamisole in the treatment of advanced breast cancer. A ten-year follow-up of a randomized study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dactinomycin; Double-Blind Method; Female; Follow-Up Studies; Humans; Immunocompetence; Levamisole; Lymphocyte Activation; Middle Aged; Vincristine | 1991 |
Prospective randomized trial concerning hyper- and normoprolactinemia and the use of bromoergocryptine in patients with metastatic breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bromocriptine; Cyclophosphamide; Dactinomycin; Female; Fluorouracil; Humans; Hyperprolactinemia; Medroxyprogesterone; Medroxyprogesterone Acetate; Methotrexate; Middle Aged; Neoplasm Metastasis; Prognosis; Prolactin; Vincristine | 1986 |
A randomised controlled trial of adjuvant hormono-chemotherapy in Stage II breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Female; Humans; Mastectomy, Simple; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Random Allocation; Tamoxifen; Vincristine | 1988 |
Clinical correlations with the human tumor cloning assay.
Topics: Aminoacridines; Amsacrine; Anthracenes; Breast Neoplasms; Clinical Trials as Topic; Clone Cells; Culture Techniques; Dactinomycin; Drug Resistance; Female; Head and Neck Neoplasms; Humans; Interferon Type I; Leukemia; Lung Neoplasms; Melanoma; Multiple Myeloma; Neoplasms; Ovarian Neoplasms; Prospective Studies; Retrospective Studies; Tumor Stem Cell Assay | 1985 |
147 other study(ies) available for dactinomycin and Breast Cancer
| Article | Year |
|---|---|
Synergistic Interactions of Cannabidiol with Chemotherapeutic Drugs in MCF7 Cells: Mode of Interaction and Proteomics Analysis of Mechanisms.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cannabidiol; Cell Line, Tumor; Cell Survival; Dactinomycin; Docetaxel; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Irinotecan; MCF-7 Cells; Paclitaxel; Proteome; Proteomics; Vinorelbine | 2021 |
Vimentin prevents a miR-dependent negative regulation of tissue factor mRNA during epithelial-mesenchymal transitions and facilitates early metastasis.
Topics: 3' Untranslated Regions; Breast Neoplasms; Cell Line, Tumor; Dactinomycin; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Neoplasm Metastasis; Neoplastic Cells, Circulating; RNA Stability; RNA, Messenger; Thromboplastin; Vimentin | 2020 |
circRNA RPPH1 Facilitates the Aggravation of Breast Cancer Development by Regulating miR-542-3p/ARHGAP1 Pathway.
Topics: Breast Neoplasms; Cadherins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dactinomycin; Female; GTPase-Activating Proteins; Humans; Ki-67 Antigen; MicroRNAs; Ribonuclease P; RNA, Circular; Vimentin | 2022 |
Actinomycin D Down-regulates SOX2 Expression and Induces Death in Breast Cancer Stem Cells.
Topics: Antibiotics, Antineoplastic; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Proliferation; Dactinomycin; Female; Gene Expression Regulation, Neoplastic; Humans; Neoplastic Stem Cells; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; SOXB1 Transcription Factors; Tumor Cells, Cultured | 2017 |
Functional disruption of the Golgi apparatus protein ARF1 sensitizes MDA-MB-231 breast cancer cells to the antitumor drugs Actinomycin D and Vinblastine through ERK and AKT signaling.
Topics: Adenocarcinoma; ADP-Ribosylation Factor 1; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dactinomycin; Golgi Apparatus; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Proto-Oncogene Proteins c-akt; Vinblastine | 2018 |
Carbon nanotube-delivered iC9 suicide gene therapy for killing breast cancer cells in vitro.
Topics: Antineoplastic Agents; Apoptosis; Base Sequence; Breast Neoplasms; Caspase 9; Cell Survival; Combined Modality Therapy; Dactinomycin; Doxorubicin; Escherichia coli; Female; Genetic Therapy; Genetic Vectors; Humans; MCF-7 Cells; Nanotubes, Carbon; Pyridines; Transfection | 2019 |
Actinomycin V Inhibits Migration and Invasion via Suppressing Snail/Slug-Mediated Epithelial-Mesenchymal Transition Progression in Human Breast Cancer MDA-MB-231 Cells In Vitro.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Dactinomycin; Epithelial-Mesenchymal Transition; Humans; Neoplasm Invasiveness; Snail Family Transcription Factors | 2019 |
Epigenetic control of endothelin-1 axis affects invasiveness of breast carcinoma cells with bone tropism.
Topics: Azacitidine; Bone Neoplasms; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Cell Movement; Collagen; Dactinomycin; DNA Methylation; Drug Combinations; Endothelin A Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Laminin; Mutation; Neoplasm Invasiveness; Peptides, Cyclic; Proteoglycans; Proto-Oncogene Protein c-ets-1; Receptor, Endothelin A; RNA Stability; RNA, Messenger; Transcription, Genetic | 2013 |
Immunostimulating effect of a well-known Thai folkloric remedy in breast cancer patients.
Topics: Adenocarcinoma; Adult; Animals; Breast Neoplasms; Case-Control Studies; Cytotoxicity, Immunologic; Dactinomycin; Female; Fibroblasts; Follow-Up Studies; Humans; Killer Cells, Natural; Lipopolysaccharides; Lymphocyte Activation; Macrophages; Mice; Mice, Inbred C3H; Middle Aged; Monocytes; Phytotherapy; Plant Extracts; Plants, Medicinal; Prognosis; Tumor Necrosis Factor-alpha | 2013 |
Regulation of PMP22 mRNA by G3BP1 affects cell proliferation in breast cancer cells.
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Carrier Proteins; Cell Proliferation; Cell Survival; Dactinomycin; DNA Helicases; Female; Gene Knockdown Techniques; Humans; MCF-7 Cells; Myelin Proteins; Poly-ADP-Ribose Binding Proteins; RNA Helicases; RNA Recognition Motif Proteins; RNA Stability; RNA, Messenger | 2013 |
Prolactin/Stat5 and androgen R1881 coactivate carboxypeptidase-D gene in breast cancer cells.
Topics: Androgens; Base Sequence; Breast Neoplasms; Consensus Sequence; Cycloheximide; Dactinomycin; Enzyme Activation; Enzyme Induction; Female; Gene Expression Regulation, Neoplastic; Humans; Interferon-gamma; MCF-7 Cells; Metribolone; Prolactin; Promoter Regions, Genetic; Protein Synthesis Inhibitors; Proteins; Receptors, Androgen; STAT5 Transcription Factor | 2014 |
Placental site trophoblastic tumor with multiple metastases and complete response to salvage BEP regimen: a case report and review of the literature.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Chorionic Gonadotropin; Cisplatin; Cyclophosphamide; Dactinomycin; Digestive System Neoplasms; Endocrine Gland Neoplasms; Etoposide; Female; Humans; Hysterectomy; Kidney Neoplasms; Lung Neoplasms; Lymph Node Excision; Methotrexate; Pelvis; Pregnancy; Trophoblastic Tumor, Placental Site; Uterine Hemorrhage; Uterine Neoplasms; Vincristine; Young Adult | 2009 |
Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells.
Topics: 3' Untranslated Regions; Apoptosis Regulatory Proteins; Breast Neoplasms; Cell Line, Tumor; Cycloheximide; Dactinomycin; Down-Regulation; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; MicroRNAs; Nucleic Acid Synthesis Inhibitors; Promoter Regions, Genetic; Protein Synthesis Inhibitors; ras GTPase-Activating Proteins; RNA-Binding Proteins; RNA, Antisense; Tamoxifen | 2009 |
Repression of SHP-1 expression by p53 leads to trkA tyrosine phosphorylation and suppression of breast cancer cell proliferation.
Topics: Breast Neoplasms; CCAAT-Binding Factor; Cell Line, Tumor; Cell Proliferation; Dactinomycin; Humans; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Receptor, trkA; Tumor Suppressor Protein p53 | 2009 |
Vacuum-assisted biopsies under MR guidance: results of 72 procedures.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Dactinomycin; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Radiography; Retrospective Studies; Tumor Burden; Vacuum; Vinblastine | 2010 |
Centchroman mediated apoptosis involves cross-talk between extrinsic/intrinsic pathways and oxidative regulation.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspases; Cell Cycle; Cell Line, Tumor; Centchroman; Cycloheximide; Dactinomycin; Down-Regulation; Estrogen Antagonists; Female; Humans; Immunoprecipitation; Oxidative Stress; Tamoxifen; Up-Regulation | 2010 |
Regulation of β-tubulin isotypes by micro-RNA 100 in MCF7 breast cancer cells.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Dactinomycin; Female; Gene Expression Regulation, Neoplastic; Humans; Microarray Analysis; MicroRNAs; Paclitaxel; Protein Isoforms; Tubulin; Tubulin Modulators | 2011 |
Transforming growth factor-β1 attenuates junctional adhesion molecule-A and contributes to breast cancer cell invasion.
Topics: Adenocarcinoma; Breast Neoplasms; Cell Adhesion Molecules; Cell Line, Tumor; Chromatin Immunoprecipitation; Clathrin; Collagen; Dactinomycin; Down-Regulation; Drug Combinations; Female; Humans; JNK Mitogen-Activated Protein Kinases; Laminin; Neoplasm Invasiveness; Neoplasm Proteins; Protease Inhibitors; Protein Processing, Post-Translational; Proteoglycans; Receptors, Cell Surface; Receptors, Transforming Growth Factor beta; RNA Interference; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering; Smad Proteins; Transcription, Genetic; Transforming Growth Factor beta1; Ubiquitination | 2012 |
Sunitinib, a tyrosine kinase inhibitor, induces cytochrome P450 1A1 gene in human breast cancer MCF7 cells through ligand-independent aryl hydrocarbon receptor activation.
Topics: Antineoplastic Agents; Breast Neoplasms; Cytochrome P-450 CYP1A1; Dactinomycin; Dose-Response Relationship, Drug; Enzyme Induction; Enzyme Inhibitors; Female; Gene Expression Regulation, Enzymologic; Humans; Indoles; Ligands; MCF-7 Cells; Protein-Tyrosine Kinases; Pyrroles; Receptors, Aryl Hydrocarbon; Resveratrol; RNA, Messenger; Stilbenes; Sunitinib; Transcriptional Activation | 2013 |
Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors.
Topics: Animals; Breast Neoplasms; CD24 Antigen; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cellular Reprogramming; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p16; Dactinomycin; Drug Resistance, Neoplasm; Epithelial Cells; Female; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; Induced Pluripotent Stem Cells; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Mammary Glands, Human; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Naphthoquinones; Neoplastic Stem Cells; Octamer Transcription Factor-3; Paclitaxel; Proto-Oncogene Proteins c-myc; Pyrans; SOXB1 Transcription Factors; Spheroids, Cellular | 2014 |
Constitutive and inducible expression of the epithelial antigen MUC1 (CD227) in human T cells.
Topics: Antibodies, Monoclonal; Antigens; Breast Neoplasms; Carcinoma, Lobular; CD3 Complex; Cell Division; Cell Membrane; Cells, Cultured; Dactinomycin; Epithelial Cells; Glycosylation; Golgi Apparatus; Humans; Leukocytes, Mononuclear; Molecular Weight; Mucin-1; Phytohemagglutinins; Protein Transport; RNA, Messenger; Solubility; T-Lymphocytes; Tetradecanoylphorbol Acetate; Transcription, Genetic | 2002 |
Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines.
Topics: Breast; Breast Neoplasms; Carcinoma; Cell Division; Cycloheximide; Dactinomycin; Drug Synergism; Epithelial Cells; Female; Gene Expression Regulation, Neoplastic; Humans; Interleukin-1; Kinetics; Male; Prostate; Protein Synthesis Inhibitors; Receptors, Estrogen; Receptors, Retinoic Acid; Recombinant Fusion Proteins; RNA, Messenger; Transcription, Genetic; Tretinoin; Tumor Cells, Cultured; Up-Regulation | 2002 |
The activation of c-Jun NH2-terminal kinase (JNK) by DNA-damaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent enhanced DNA repair.
Topics: Activating Transcription Factor 2; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cisplatin; Cyclic AMP Response Element-Binding Protein; Dactinomycin; DNA Damage; DNA Repair; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Gastrointestinal Agents; Humans; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Phenotype; Transcription Factors; Transcriptional Activation; Tumor Cells, Cultured; Vitamin U | 2003 |
Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel, estrogen receptor-independent cytostatic mechanism.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclases; Antineoplastic Agents, Phytogenic; Arachidonic Acids; Breast Neoplasms; Cell Division; Cyclic AMP; Cyclic GMP; Dactinomycin; Enzyme Activation; Enzyme Inhibitors; Female; Guanylate Cyclase; Humans; Receptors, Estrogen; Resveratrol; Rolipram; Stilbenes; Tamoxifen; Tumor Cells, Cultured | 2003 |
Effects of the phytoestrogens genistein and daidzein on BRCA2 tumor suppressor gene expression in breast cell lines.
Topics: Antibiotics, Antineoplastic; BRCA2 Protein; Breast Neoplasms; Cell Division; Cell Line; Chromatography, Affinity; Cycloheximide; Dactinomycin; Gene Expression Regulation, Neoplastic; Genes, BRCA2; Genistein; Humans; Isoflavones; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured | 2003 |
AURANTIN--A COMPLEX ANTIBIOTIC SUBSTANCE OF THE ACTINOMYCIN GROUP: ITS PROPERTIES AND RESULTS OF CLINICAL TRIALS ON VARIOUS TYPES OF NEOPLASMS.
Topics: Adenocarcinoma; Adrenal Cortex Hormones; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Brain Neoplasms; Breast Neoplasms; Carcinoma, Ehrlich Tumor; Dactinomycin; Dysgerminoma; Female; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Melanoma; Mice; Neoplasms; Neoplasms, Experimental; Ovarian Neoplasms; Pharmacology; Rabbits; Rectal Neoplasms; Research; Sarcoma; Sarcoma, Experimental; Tissue Culture Techniques | 1964 |
EXPERIENCE WITH CHEMOTHERAPY OF CANCER AT THE UNIVERSITY OF PRETORIA.
Topics: Antineoplastic Agents; Aziridines; Breast Neoplasms; Cyclophosphamide; Dactinomycin; Fluorouracil; Hodgkin Disease; Humans; Intestinal Neoplasms; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Lymphoma, Non-Hodgkin; Mannomustine; Mesothelioma; Multiple Myeloma; Neoplasms; Pancreatic Neoplasms; Sarcoma; South Africa; Stomach Neoplasms; Vinblastine | 1964 |
[CHEMOTHERAPY OF MALIGNANT NEOPLASMS].
Topics: Alkylating Agents; Animals; Antimetabolites; Antineoplastic Agents; Breast Neoplasms; Choriocarcinoma; Dactinomycin; Female; Gastrointestinal Neoplasms; Hodgkin Disease; Humans; Leukemia; Lung Neoplasms; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Multiple Myeloma; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Polycythemia Vera; Pregnancy; Sarcoma; Wilms Tumor | 1964 |
THE UTILITY OF A CARCINOGEN-INDUCED RAT MAMMARY CANCER AS A CHEMOTHERAPEUTIC SCREENING DEVICE.
Topics: Animals; Breast Neoplasms; Carcinogens; Cyclophosphamide; Dactinomycin; Diet; Diet Therapy; Humans; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Mechlorethamine; Mercaptopurine; Methotrexate; Methylcholanthrene; Neoplasms; Rats; Research; Toxicology | 1965 |
MnSOD up-regulates maspin tumor suppressor gene expression in human breast and prostate cancer cells.
Topics: Adenoviridae; Base Sequence; Blotting, Northern; Blotting, Western; Breast Neoplasms; Cell Line; Cell Line, Tumor; Dactinomycin; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Genetic Vectors; Humans; Kinetics; Male; Molecular Sequence Data; Mutation; Promoter Regions, Genetic; Prostatic Neoplasms; Proteins; RNA Stability; RNA, Messenger; Serpins; Superoxide Dismutase; Transcription, Genetic; Transfection; Tumor Suppressor Protein p53; Up-Regulation | 2003 |
Hemopoietic recovery and infectious complications in breast cancer and multiple myeloma after autologous CD34+ cell-selected peripheral blood progenitor cell transplantation.
Topics: Adult; Aged; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Graft Survival; Hematopoiesis; Humans; Idarubicin; Ifosfamide; Infections; Male; Middle Aged; Multiple Myeloma; Neutropenia; Peripheral Blood Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine; Whole-Body Irradiation | 2004 |
Augmented release of matrix metalloproteinase-9 by PKC activation in organotypic cultures of human breast cancer and adjacent normal breast tissue and fibroadenoma.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Breast; Breast Neoplasms; Concanavalin A; Cycloheximide; Dactinomycin; Enzyme Activation; Enzyme Activators; Female; Fibroadenoma; Gelatin; Humans; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Organ Culture Techniques; Protease Inhibitors; Protein Biosynthesis; Protein Kinase C; Protein Synthesis Inhibitors; Transcription, Genetic | 2004 |
Membrane 5alpha-pregnane-3,20-dione (5alphaP) receptors in MCF-7 and MCF-10A breast cancer cells are up-regulated by estradiol and 5alphaP and down-regulated by the progesterone metabolites, 3alpha-dihydroprogesterone and 20alpha-dihydroprogesterone, with
Topics: 20-alpha-Dihydroprogesterone; 5-alpha-Dihydroprogesterone; Antineoplastic Agents; Breast Neoplasms; Cell Adhesion; Cell Fractionation; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Cycloheximide; Dactinomycin; Down-Regulation; Estradiol; Female; Humans; Progesterone; Receptors, Estradiol; Receptors, Progesterone; Up-Regulation | 2005 |
Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repressor HBP1.
Topics: Blotting, Western; Breast Neoplasms; Catechin; Cell Line; Cell Line, Tumor; Cell Movement; Dactinomycin; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Genes, Reporter; High Mobility Group Proteins; Humans; Models, Biological; Phosphorylation; Plasmids; Proto-Oncogene Proteins c-myc; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Signal Transduction; Tea; Time Factors; Transcription, Genetic; Transfection; Wnt Proteins | 2006 |
Sulindac regulates the aryl hydrocarbon receptor-mediated expression of Phase 1 metabolic enzymes in vivo and in vitro.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Hepatocellular; Cytochrome P-450 CYP1A1; Dactinomycin; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Humans; In Vitro Techniques; Liver; Liver Neoplasms; Male; Promoter Regions, Genetic; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Aryl Hydrocarbon; RNA, Messenger; Sulindac; Transcription, Genetic; Tumor Cells, Cultured; Xenobiotics | 2006 |
Primary rhabdomyosarcoma of the breast in a 13-year-old girl: report of a case.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Dactinomycin; Doxorubicin; Fatal Outcome; Female; Humans; Ifosfamide; Lung Neoplasms; Mastectomy; Rhabdomyosarcoma, Alveolar | 2007 |
Regulation of growth hormone signaling by selective estrogen receptor modulators occurs through suppression of protein tyrosine phosphatases.
Topics: Breast Neoplasms; Cell Line, Tumor; Dactinomycin; Estrogen Antagonists; Estrogens; Human Growth Hormone; Humans; Intracellular Signaling Peptides and Proteins; Janus Kinase 2; Kidney; Protein Synthesis Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Raloxifene Hydrochloride; Receptors, Estrogen; Signal Transduction; STAT5 Transcription Factor; Suppressor of Cytokine Signaling Proteins; Tamoxifen | 2007 |
Study of optical parameters of the nucleoli under the effect of transcription inhibitors by coherent phase microscopy.
Topics: 3T3 Cells; Animals; Breast Neoplasms; Cell Line, Tumor; Cell Nucleolus; Dactinomycin; Female; Humans; Kinetics; Mice; Rectal Neoplasms; Transcription, Genetic | 2006 |
Enzastaurin renders MCF-7 breast cancer cells sensitive to radiation through reversal of radiation-induced activation of protein kinase C.
Topics: Annexin A5; Apoptosis; Blotting, Western; Breast Neoplasms; Caspase 3; Caspase 9; Cell Survival; Cytosol; Dactinomycin; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Gamma Rays; Humans; Indoles; Phosphorylation; Protein Kinase C; Radiation-Sensitizing Agents; Repressor Proteins; Tumor Cells, Cultured | 2008 |
[Generalized metastasizing chorion carcinoma with complete remission after cytostatic therapy].
Topics: Adult; Breast Neoplasms; Chlorambucil; Choriocarcinoma; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Female; Humans; Liver Neoplasms; Lung Neoplasms; Methotrexate; Pregnancy; Uterine Neoplasms; Vaginal Neoplasms | 1983 |
Kinetic alterations in estrogen receptors associated with estrogen receptor processing in human breast cancer cells.
Topics: Binding Sites; Breast Neoplasms; Cells, Cultured; Dactinomycin; Estradiol; Female; Humans; Kinetics; Perfusion; Protein Biosynthesis; Receptors, Estrogen; RNA; Time Factors | 1984 |
Estradiol preferentially enhances extracellular tissue plasminogen activators of MCF-7 breast cancer cells.
Topics: Breast Neoplasms; Cell Line; Cycloheximide; Dactinomycin; Dexamethasone; Electrophoresis, Polyacrylamide Gel; Estradiol; Female; Humans; Kinetics; Molecular Weight; Plasminogen Activators; Progesterone; Testosterone | 1984 |
Thyroid hormone-inducible mitochondrial alpha-glycerophosphate dehydrogenase in the MCF-7 human breast cancer cell line.
Topics: Breast Neoplasms; Cell Line; Dactinomycin; Enzyme Induction; Glycerolphosphate Dehydrogenase; Humans; Mitochondria; Puromycin; Triiodothyronine | 1983 |
Nuclear estrogen receptors. Effect of inhibitors on processing and steady state levels.
Topics: Binding, Competitive; Breast Neoplasms; Cell Line; Cell Nucleus; Cycloheximide; Cytosol; Dactinomycin; Deoxyadenosines; Estradiol; Female; Humans; Kinetics; Receptors, Estrogen | 1980 |
Nuclear estrogen receptor release from antiestrogen suppression: amplified induction of progesterone receptor in MCF-7 human breast cancer cells.
Topics: Breast Neoplasms; Cell Line; Cell Nucleus; Dactinomycin; Estradiol; Female; Humans; Kinetics; Nafoxidine; Promegestone; Pyrrolidines; Receptors, Estrogen; Receptors, Progesterone | 1981 |
Angiosarcoma and other vascular tumors of the breast.
Topics: Adult; Antineoplastic Agents; Breast Diseases; Breast Neoplasms; Dactinomycin; Female; Hemangiosarcoma; Humans; Mastectomy; Prognosis | 1981 |
Actinomycin D in the treatment of advanced breast cancer.
Topics: Breast Neoplasms; Dactinomycin; Drug Evaluation; Female; Humans; Neoplasm Metastasis | 1980 |
Circumvention of P-glycoprotein-mediated multiple drug resistance by phosphorylation modulators is independent of protein kinases.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Line; Dactinomycin; Doxorubicin; Drug Resistance, Multiple; Enzyme Activation; Enzyme Inhibitors; Female; Humans; Kinetics; Phorbol Esters; Phosphoprotein Phosphatases; Phosphorylation; Protein Kinase Inhibitors; Protein Kinases; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Vinblastine | 1995 |
Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells.
Topics: Breast Neoplasms; Concanavalin A; Cycloheximide; Dactinomycin; Dose-Response Relationship, Drug; Enzyme Activation; Gelatinases; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinases, Membrane-Associated; Metalloendopeptidases; Protein Precursors; RNA, Messenger; Tumor Cells, Cultured | 1995 |
Angiosarcoma of the breast and pregnancy: a new therapeutic approach.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dactinomycin; Female; Hemangiosarcoma; Humans; Ifosfamide; Mastectomy, Simple; Pregnancy; Pregnancy Complications, Neoplastic; Vincristine | 1995 |
1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor beta 1 and its latent form binding protein in cultured breast carcinoma cells.
Topics: Breast Neoplasms; Calcitriol; Carrier Proteins; Cycloheximide; Dactinomycin; Humans; Intracellular Signaling Peptides and Proteins; Latent TGF-beta Binding Proteins; Receptors, Transforming Growth Factor beta; RNA, Messenger; Transforming Growth Factor beta; Tumor Cells, Cultured | 1995 |
Effect of basic fibroblast growth factor on synthesis/secretion of pS2 protein by human breast cancer cells (MCF-7).
Topics: Breast Neoplasms; Cycloheximide; Dactinomycin; Drug Synergism; Estradiol; Female; Fibroblast Growth Factor 2; Humans; Kinetics; Neoplasm Proteins; Proteins; RNA, Messenger; Steroids; Trefoil Factor-1; Tumor Cells, Cultured; Tumor Suppressor Proteins | 1994 |
In vivo generation of highly abundant sequence-specific oligonucleotides for antisense and triplex gene regulation.
Topics: Base Sequence; Breast Neoplasms; Cell Line; Chimera; Cloning, Molecular; Dactinomycin; Female; Gene Expression Regulation; Humans; Kidney; Kinetics; Molecular Sequence Data; Nucleic Acid Conformation; Oligodeoxyribonucleotides; Oligonucleotides, Antisense; RNA, Small Nuclear; Transfection; Tumor Cells, Cultured | 1994 |
Epidermal growth factor and insulin-like growth factor-1 protect MDA-231 cells from death induced by actinomycin D: the involvement of growth factors in drug resistance.
Topics: Breast Neoplasms; Cell Death; Dactinomycin; Drug Resistance; Epidermal Growth Factor; Humans; Insulin-Like Growth Factor I; Time Factors; Tumor Cells, Cultured | 1994 |
Inhibition of transcription selectively reduces the level of ubiquitinated histone H2B in chromatin.
Topics: Animals; Breast Neoplasms; Cell Line; Chlorocebus aethiops; CHO Cells; Chromatin; Cricetinae; Dactinomycin; Dichlororibofuranosylbenzimidazole; Electrophoresis, Polyacrylamide Gel; Female; Histones; Humans; Kidney; Transcription, Genetic; Tumor Cells, Cultured; Ubiquitins | 1994 |
Expression of the c-erbB2 gene in the BT474 human mammary tumor cell line: measurement of c-erbB2 mRNA half-life.
Topics: Adenocarcinoma; Breast Neoplasms; Cycloheximide; Dactinomycin; Female; Gene Expression Regulation, Neoplastic; Humans; In Vitro Techniques; Proto-Oncogene Proteins; Proto-Oncogenes; Receptor, ErbB-2; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured | 1993 |
Reversal of the human and murine multidrug-resistance phenotype with megestrol acetate.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Colonic Neoplasms; Dactinomycin; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Female; Flow Cytometry; Humans; Mammary Neoplasms, Experimental; Megestrol; Megestrol Acetate; Mice; Mice, Nude; Neoplasm Transplantation; Phenotype; Transplantation, Heterologous; Tumor Cells, Cultured | 1994 |
Estrogen-inducible pS2 protein is not the key regulatory component in the proliferation of human breast cancer cells (MCF-7).
Topics: Biological Transport; Breast Neoplasms; Cell Division; Dactinomycin; DNA, Neoplasm; Estrogens; Genes, fos; Humans; Neoplasm Proteins; Protein Kinase C; Proteins; RNA, Neoplasm; Tetradecanoylphorbol Acetate; Trefoil Factor-1; Tumor Cells, Cultured; Tumor Suppressor Proteins | 1993 |
Interleukin 6 stimulates the production of immunoreactive endothelin 1 in human breast cancer cells.
Topics: Breast Neoplasms; Cycloheximide; Cytokines; Dactinomycin; Endothelins; Estrogens; Humans; Interleukin-6; Stimulation, Chemical; Tamoxifen; Tumor Cells, Cultured | 1993 |
Quantitation of the nucleophosmin/B23-translocation using imaging analysis.
Topics: Aclarubicin; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Nucleolus; Dactinomycin; Daunorubicin; Dose-Response Relationship, Drug; Fluorescent Antibody Technique; Humans; Image Processing, Computer-Assisted; Leukemia, Monocytic, Acute; Nuclear Proteins; Nucleophosmin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured | 1996 |
Molecular effects of genistein on estrogen receptor mediated pathways.
Topics: Anticarcinogenic Agents; Breast Neoplasms; Dactinomycin; Estradiol; Estrogen Antagonists; Genistein; Humans; Isoflavones; Neoplasm Proteins; Protein Synthesis Inhibitors; Proteins; Receptors, Estrogen; RNA, Messenger; Trefoil Factor-1; Tumor Cells, Cultured; Tumor Suppressor Proteins | 1996 |
Upregulation of cytokeratins 8 and 18 in human breast cancer T47D cells is retinoid-specific and retinoic acid receptor-dependent.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Breast Neoplasms; Dactinomycin; Female; Gene Expression Regulation; Humans; Keratins; Receptors, Retinoic Acid; Retinoid X Receptors; RNA, Messenger; Transcription Factors; Tretinoin; Up-Regulation | 1996 |
17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells.
Topics: Breast Neoplasms; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinases; Cyclins; Dactinomycin; DNA; Estradiol; Female; G1 Phase; Gene Expression; Genes, Reporter; Humans; Lovastatin; Luciferases; Oncogene Proteins; Phosphorylation; Proto-Oncogene Proteins; Retinoblastoma Protein; RNA, Messenger; Simvastatin; Transcription, Genetic; Transfection; Tumor Cells, Cultured | 1996 |
Bimodal regulation of epidermal growth factor receptor by estrogen in breast cancer cells.
Topics: Base Sequence; Breast Neoplasms; Cell Line; Cell Nucleus; Consensus Sequence; Cycloheximide; Dactinomycin; Down-Regulation; ErbB Receptors; Estradiol; Estrogen Antagonists; Female; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Models, Biological; Molecular Sequence Data; Polyunsaturated Alkamides; Promoter Regions, Genetic; RNA, Messenger; Time Factors; Transcription, Genetic; Tumor Cells, Cultured; Up-Regulation | 1996 |
Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells.
Topics: Breast Neoplasms; Cell Division; Dactinomycin; Estradiol; Estrogen Antagonists; Female; Humans; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor I; Plasmids; Protein Synthesis Inhibitors; Receptors, Estrogen; Recombinant Proteins; Signal Transduction; Tamoxifen; Transcriptional Activation; Tumor Cells, Cultured | 1997 |
Transcriptional and post-transcriptional mechanisms can regulate cell-specific expression of the human Pi-class glutathione S-transferase gene.
Topics: Base Sequence; Breast Neoplasms; Cell Line; Cell Nucleus; Dactinomycin; Female; Gene Expression Regulation, Enzymologic; Glutathione Transferase; Humans; Isoenzymes; Kinetics; Molecular Sequence Data; Mutagenesis, Site-Directed; Oligonucleotide Probes; Organ Specificity; Promoter Regions, Genetic; Recombinant Proteins; RNA Processing, Post-Transcriptional; RNA, Messenger; Sequence Deletion; Transcription, Genetic; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1997 |
Oncostatin M-mediated transcriptional suppression of the c-myc gene in breast cancer cells.
Topics: Antineoplastic Agents; Blotting, Northern; Breast Neoplasms; Carcinoma; Dactinomycin; Dose-Response Relationship, Drug; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Genes, myc; Humans; Nucleic Acid Synthesis Inhibitors; Oncostatin M; Peptides; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured | 1997 |
Effects of cytotoxic drugs on translocation of nucleolar RNA helicase RH-II/Gu.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Biological Transport; Breast Neoplasms; Cell Nucleolus; Dactinomycin; Guanosine; Humans; Mycophenolic Acid; RNA Helicases; RNA Nucleotidyltransferases; Toyocamycin; Tumor Cells, Cultured | 1997 |
Growth inhibition of human breast cancer cells by 1,25-dihydroxyvitamin D3 is accompanied by induction of apolipoprotein D expression.
Topics: Antineoplastic Agents; Apolipoproteins; Apolipoproteins D; Breast Neoplasms; Calcitriol; Carcinoma; Cycloheximide; Dactinomycin; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Growth Inhibitors; Humans; Protein Synthesis Inhibitors; RNA, Messenger; RNA, Neoplasm; Time Factors; Tumor Cells, Cultured | 1997 |
Abundance of BRCA1 transcripts in human cancer and lymphoblastoid cell lines carrying BRCA1 germ-line alterations.
Topics: Breast Neoplasms; Cell Line, Transformed; Dactinomycin; DNA Primers; Female; Genes, BRCA1; Half-Life; Humans; Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Transcription, Genetic; Tumor Cells, Cultured | 1997 |
Activation of tissue-factor gene expression in breast carcinoma cells by stimulation of the RAF-ERK signaling pathway.
Topics: Base Sequence; Benzoquinones; Breast Neoplasms; Calcium-Calmodulin-Dependent Protein Kinases; Dactinomycin; DNA, Complementary; Enzyme Activation; Enzyme Induction; Enzyme Inhibitors; Female; Flavonoids; Gene Expression Regulation, Neoplastic; Genistein; Humans; Hydroquinones; Lactams, Macrocyclic; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Molecular Sequence Data; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neovascularization, Pathologic; NF-kappa B; Okadaic Acid; Phenols; Proto-Oncogene Proteins c-raf; Quinones; Rifabutin; Signal Transduction; Tetradecanoylphorbol Acetate; Thromboplastin; Transcription Factor AP-1; Transcription, Genetic; Tretinoin; Tumor Cells, Cultured | 1998 |
Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage.
Topics: Animals; Breast Neoplasms; Cell Cycle; Cell Cycle Proteins; Cell Division; Cells, Cultured; Chromosome Mapping; Chromosomes, Human, Pair 8; Dactinomycin; DNA Damage; Doxorubicin; Epithelial Cells; Female; Gene Library; Genes, p53; Humans; Intracellular Signaling Peptides and Proteins; Male; Mice; Mitomycin; Polymerase Chain Reaction; Prostatic Neoplasms; Recombinant Fusion Proteins; RNA, Messenger; Transcription, Genetic; Transfection; Tumor Cells, Cultured; Tumor Stem Cell Assay; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms | 1998 |
Estrogenic and anti-estrogenic regulation of estrogen receptor in MCF-7 breast-cancer cells: comparison of immunocytochemical data with biochemical measurements.
Topics: Breast Neoplasms; Cycloheximide; Dactinomycin; Down-Regulation; Estradiol; Estrogen Antagonists; Estrogens; Humans; Immunoenzyme Techniques; Immunohistochemistry; Kinetics; Okadaic Acid; Polyunsaturated Alkamides; Receptors, Estrogen; Tamoxifen; Time Factors; Tumor Cells, Cultured | 1998 |
Stimulation of PC cell-derived growth factor (epithelin/granulin precursor) expression by estradiol in human breast cancer cells.
Topics: Blotting, Western; Breast; Breast Neoplasms; Culture Media, Conditioned; Cycloheximide; Dactinomycin; Dose-Response Relationship, Drug; Epithelial Cells; Estradiol; Estrogen Antagonists; Gene Expression Regulation; Glycoproteins; Granulins; Growth Substances; Humans; Intercellular Signaling Peptides and Proteins; Progranulins; Protein Precursors; RNA, Messenger; Tamoxifen; Time Factors; Tumor Cells, Cultured | 1999 |
In vitro changes of the nuclear AgNORs pattern induced by RNA inhibitors and 5-fluorouracil in human breast cancer cells, MCF-7 and HBC-4.
Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Cell Count; Dactinomycin; Fluorouracil; Humans; Nucleic Acid Synthesis Inhibitors; Nucleolus Organizer Region; Silver Staining; Tumor Cells, Cultured | 1998 |
Estrogen inducibility of c-Ha-ras transcription in breast cancer cells. Identification of functional estrogen-responsive transcriptional regulatory elements in exon 1/intron 1 of the c-Ha-ras gene.
Topics: Animals; Breast Neoplasms; Chloramphenicol O-Acetyltransferase; Cycloheximide; Dactinomycin; Dexamethasone; Estradiol; Exons; Female; Gene Expression Regulation, Neoplastic; Genes, ras; Humans; Introns; Mice; Proto-Oncogene Proteins p21(ras); Recombinant Fusion Proteins; Regulatory Sequences, Nucleic Acid; RNA, Messenger; Transcription, Genetic; Transfection; Tumor Cells, Cultured | 1999 |
Androgens down-regulate the expression of the human homologue of paternally expressed gene-3 in the prostatic adenocarcinoma cell line LNCaP.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Cycloheximide; Dactinomycin; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Kruppel-Like Transcription Factors; Male; Metribolone; Mice; Polymerase Chain Reaction; Prostatic Neoplasms; Protein Kinases; Proteins; Receptors, Androgen; RNA, Messenger; Testosterone Congeners; Transcription Factors; Transcription, Genetic; Tumor Cells, Cultured; Zinc Fingers | 1999 |
A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals.
Topics: Amino Acid Sequence; Antibiotics, Antineoplastic; Base Sequence; Breast Neoplasms; Carrier Proteins; Cell Nucleus; Dactinomycin; Databases as Topic; DNA-Binding Proteins; Exportin 1 Protein; Fatty Acids, Unsaturated; Female; Gene Products, rev; Green Fluorescent Proteins; HIV-1; Humans; I-kappa B Proteins; Karyopherins; Luminescent Proteins; Melanoma; Molecular Sequence Data; NF-KappaB Inhibitor alpha; Nuclear Proteins; Proto-Oncogene Proteins c-abl; Receptors, Cytoplasmic and Nuclear; rev Gene Products, Human Immunodeficiency Virus; Sequence Alignment; Sequence Homology, Amino Acid; Templates, Genetic; Tumor Cells, Cultured | 2000 |
Identification and characterization of amino acid starvation-induced CD24 gene in MCF-7 human breast cancer cells.
Topics: Amino Acids; Antigens, CD; Breast; Breast Neoplasms; CD24 Antigen; Cell Line; Dactinomycin; Gene Expression Regulation; Humans; Membrane Glycoproteins; RNA, Messenger; Tumor Cells, Cultured | 2000 |
Diverse chemical carcinogens fail to induce G(1) arrest in MCF-7 cells.
Topics: 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; Acetoxyacetylaminofluorene; Alkylating Agents; Breast Neoplasms; Carcinogens; Cell Cycle; Cell Survival; Dactinomycin; Dose-Response Relationship, Drug; G1 Phase; Humans; Methylnitronitrosoguanidine; Nocodazole; Stereoisomerism; Tumor Cells, Cultured | 2000 |
WISP-2 as a novel estrogen-responsive gene in human breast cancer cells.
Topics: Air Pollutants, Occupational; Benzhydryl Compounds; Breast Neoplasms; CCN Intercellular Signaling Proteins; Cycloheximide; Dactinomycin; Dose-Response Relationship, Drug; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Intercellular Signaling Peptides and Proteins; Keratins; Neoplasm Proteins; Phenols; Repressor Proteins; RNA, Messenger; Time Factors; Transcription Factors; Tumor Cells, Cultured | 2000 |
Serum withdrawal-induced post-transcriptional stabilization of cyclooxygenase-2 mRNA in MDA-MB-231 mammary carcinoma cells requires the activity of the p38 stress-activated protein kinase.
Topics: Apoptosis; Blotting, Northern; Blotting, Western; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Nucleus; Culture Media, Serum-Free; Cyclooxygenase 2; Dactinomycin; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Genes, Dominant; Humans; Imidazoles; Isoenzymes; Membrane Proteins; Microscopy, Fluorescence; Mitogen-Activated Protein Kinases; Nucleic Acid Synthesis Inhibitors; p38 Mitogen-Activated Protein Kinases; Prostaglandin-Endoperoxide Synthases; Pyridines; RNA Processing, Post-Transcriptional; RNA, Messenger; Signal Transduction; Time Factors; Transfection; Tumor Cells, Cultured | 2000 |
Downregulation of VPAC1R expression in breast cancer cell lines.
Topics: Breast; Breast Neoplasms; Dactinomycin; Down-Regulation; Estradiol; Estrogen Receptor Modulators; Female; Humans; Receptors, Vasoactive Intestinal Peptide; Receptors, Vasoactive Intestinal Polypeptide, Type I; RNA, Messenger; RNA, Neoplasm; Transcription, Genetic; Transfection; Tumor Cells, Cultured; Vasoactive Intestinal Peptide | 2000 |
Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells.
Topics: Alternative Splicing; Antimetabolites, Antineoplastic; Blotting, Northern; Breast Neoplasms; Culture Media; Dactinomycin; Dose-Response Relationship, Drug; Endothelial Growth Factors; Enzyme-Linked Immunosorbent Assay; Estrogens; Glucocorticoids; Hormone Antagonists; Humans; Lymphokines; Medroxyprogesterone Acetate; Mifepristone; Progesterone; Progestins; Protein Isoforms; Protein Synthesis Inhibitors; Puromycin; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |
Cyr61, a member of the CCN family, is required for MCF-7 cell proliferation: regulation by 17beta-estradiol and overexpression in human breast cancer.
Topics: Adenocarcinoma; Antibodies; Breast Neoplasms; Cell Division; Cysteine-Rich Protein 61; Dactinomycin; DNA, Neoplasm; Epidermal Growth Factor; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Fulvestrant; Gene Expression Regulation, Neoplastic; Growth Substances; Humans; Immediate-Early Proteins; In Situ Hybridization; Intercellular Signaling Peptides and Proteins; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcriptional Activation; Tumor Cells, Cultured | 2001 |
Human cyclophilin 40 is a heat shock protein that exhibits altered intracellular localization following heat shock.
Topics: Arsenites; Breast Neoplasms; Carrier Proteins; Cell Nucleolus; Cyclophilins; Dactinomycin; Female; Gene Expression; Heat-Shock Proteins; Heat-Shock Response; Hot Temperature; Humans; Immunohistochemistry; Nucleic Acid Synthesis Inhibitors; Peptidyl-Prolyl Isomerase F; Peptidylprolyl Isomerase; RNA, Messenger; Sodium Compounds; Tacrolimus Binding Proteins; Tumor Cells, Cultured | 2001 |
Early de novo gene expression is required for 15-deoxy-Delta 12,14-prostaglandin J2-induced apoptosis in breast cancer cells.
Topics: Apoptosis; Blotting, Northern; Blotting, Western; Breast Neoplasms; Caspases; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cycloheximide; Dactinomycin; DNA, Complementary; Down-Regulation; Enzyme Activation; Flow Cytometry; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Immunologic Factors; Ligands; Microscopy, Fluorescence; Nucleic Acid Synthesis Inhibitors; Oligonucleotide Array Sequence Analysis; Prostaglandin D2; Protein Synthesis Inhibitors; Receptors, Cytoplasmic and Nuclear; S Phase; Time Factors; Transcription Factors; Transcription, Genetic; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Up-Regulation | 2001 |
Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines.
Topics: Antineoplastic Agents; Apoptosis; Benzylidene Compounds; Breast Neoplasms; Caspases; Cyclophosphamide; Dactinomycin; DNA Damage; Drug Synergism; Haloperidol; Humans; Ligands; Morphinans; Receptors, sigma; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2002 |
Role of Smad1 and Smad4 proteins in the induction of p21WAF1,Cip1 during bone morphogenetic protein-induced growth arrest in human breast cancer cells.
Topics: Blotting, Northern; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Breast Neoplasms; Cell Division; Cell Line; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cycloheximide; Dactinomycin; Depression, Chemical; DNA-Binding Proteins; Female; Humans; Immunoblotting; RNA, Messenger; Smad Proteins; Smad1 Protein; Smad4 Protein; Trans-Activators; Transforming Growth Factor beta | 2002 |
Protease inhibitor-induced stabilization of p21(waf1/cip1) and cell-cycle arrest in chemical carcinogen-exposed mammary and lung cells.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Breast Neoplasms; Carcinogens; Cell Cycle; Chrysenes; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cysteine Proteinase Inhibitors; Dactinomycin; Epithelial Cells; Flow Cytometry; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Lung; Mice; Nocodazole; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2002 |
Differential effects of fibroblast growth factors on expression of genes of the plasminogen activator and insulin-like growth factor systems by human breast fibroblasts.
Topics: Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Cells, Cultured; Cycloheximide; Dactinomycin; Enzyme Induction; Female; Fibroblast Growth Factors; Fibroblasts; Gene Expression Regulation; Humans; Insulin-Like Growth Factor Binding Proteins; Nucleic Acid Synthesis Inhibitors; Plasminogen Activator Inhibitor 1; Plasminogen Activator Inhibitor 2; Plasminogen Activators; Polymerase Chain Reaction; Protein Biosynthesis; Protein Isoforms; Protein Synthesis Inhibitors; Receptors, Somatomedin; RNA, Messenger; RNA, Neoplasm; Serine Endopeptidases; Somatomedins; Transcription, Genetic | 2002 |
Evidence that inhibition of p44/42 mitogen-activated protein kinase signaling is a factor in proteasome inhibitor-mediated apoptosis.
Topics: Apoptosis; Breast Neoplasms; Butadienes; Chymotrypsin; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dactinomycin; Enzyme Inhibitors; Female; Flavonoids; Humans; Kinetics; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Multienzyme Complexes; Nitriles; Oligopeptides; Proteasome Endopeptidase Complex; Tumor Cells, Cultured | 2002 |
Evaluation of a gemcitabine-doxorubicin-paclitaxel combination schedule through flow cytometry assessment of apoptosis extent induced in human breast cancer cell lines.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Division; Cell Survival; Clinical Trials as Topic; Dactinomycin; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Flow Cytometry; Gemcitabine; Humans; Paclitaxel; Time Factors; Tumor Cells, Cultured | 2002 |
Sensitivity tests of tumors to cytostatic agents. II. Investigation on human tumors.
Topics: Antineoplastic Agents; Autoradiography; Breast Neoplasms; Cell Count; Cell Division; Culture Techniques; Dactinomycin; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Neoplasms; Nucleic Acids; Ovarian Neoplasms; Procarbazine; Uridine | 1975 |
Cytostatic efficacy of DNA-complexes of adriamycin, daunomycin and actinomycin D. I. Comparative studies in Novikoff hepatoma, human mammary carcinoma cells and human leukemic leukocytes.
Topics: Acute Disease; Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Hepatocellular; Dactinomycin; Daunorubicin; DNA, Neoplasm; Doxorubicin; Female; Humans; Leukemia; Liver Neoplasms; Pinocytosis; Rats; RNA, Neoplasm | 1977 |
Actinomycin D prevents nuclear processing of estrogen receptor.
Topics: Breast Neoplasms; Cell Nucleus; Cells, Cultured; Dactinomycin; Dose-Response Relationship, Drug; Estradiol; Receptors, Estrogen | 1978 |
Insulin stimulation of fatty acid synthesis in human breast cancer in long term tissue culture.
Topics: Acetates; Breast Neoplasms; Cells, Cultured; Cycloheximide; Dactinomycin; Dihydrotestosterone; Estradiol; Female; Glucose; Humans; Insulin; Lipids | 1977 |
[Cytostatic therapy of inoperable carcinomas].
Topics: Breast Neoplasms; Bronchial Neoplasms; Chlorambucil; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Male; Methotrexate; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Pregnancy; Procarbazine; Testicular Neoplasms; Vinblastine; Vincristine | 1976 |
Hormone responsive human breast cancer in long-term tissue culture: effect of insulin.
Topics: Breast Neoplasms; Cell Division; Cell Line; Culture Techniques; Dactinomycin; Dexamethasone; DNA, Neoplasm; Glucose; Humans; Insulin; Neoplasm Proteins; Neoplasms, Experimental; RNA, Neoplasm | 1976 |
Immunotherapy and chemotherapy of gynecologic cancers.
Topics: BCG Vaccine; Breast Neoplasms; Dactinomycin; DNA, Neoplasm; Doxorubicin; Female; Genital Neoplasms, Female; Humans; Immunotherapy; Lymphocytes; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Recurrence; Uterine Cervical Neoplasms | 1976 |
A pharmacokinetically based phase I-II study of single-dose actinomycin D (NSC-3053).
Topics: Agranulocytosis; Animals; Biological Availability; Breast Neoplasms; Dactinomycin; Dogs; Half-Life; Humans; Melanoma; Mice; Neoplasm Metastasis; Sarcoma | 1976 |
Insulin-like growth factor binding protein-5 gene expression is differentially regulated at a post-transcriptional level in retinoic acid-sensitive and resistant MCF-7 human breast carcinoma cells.
Topics: Breast Neoplasms; Carcinoma; Carrier Proteins; Dactinomycin; Drug Resistance; Gene Expression Regulation, Neoplastic; Insulin-Like Growth Factor Binding Proteins; RNA Processing, Post-Transcriptional; RNA, Messenger; Somatomedins; Time Factors; Tretinoin; Tumor Cells, Cultured | 1992 |
Transcriptional downregulation of gap-junction proteins blocks junctional communication in human mammary tumor cell lines.
Topics: Amino Acid Sequence; Animals; Base Sequence; Breast; Breast Neoplasms; Cell Communication; Cell Cycle; Cell Line; Connexin 26; Connexins; Cycloheximide; Dactinomycin; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Intercellular Junctions; Membrane Proteins; Molecular Sequence Data; Nucleic Acid Hybridization; Rats; Sequence Homology, Nucleic Acid; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1992 |
Regulation of insulin receptor gene expression. Cell cycle-mediated effects on insulin receptor mRNA stability.
Topics: Actins; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Cycle; Cell Division; Cycloheximide; Dactinomycin; DNA Probes; Exons; Female; Gene Expression Regulation, Neoplastic; Histones; Humans; Kinetics; Liver Neoplasms; Receptor, Insulin; Restriction Mapping; RNA, Messenger; Tumor Cells, Cultured | 1992 |
Down-regulation of messenger ribonucleic acid (mRNA) for the estrogen receptor (ER) by phorbol ester requires ongoing RNA synthesis but not protein synthesis. Is hormonal control of ER mRNA degradation mediated by an RNA molecule?
Topics: Breast Neoplasms; Carcinoma; Cycloheximide; Dactinomycin; Dichlororibofuranosylbenzimidazole; Hormones; Humans; Puromycin; Receptors, Estrogen; RNA; RNA, Messenger; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1992 |
Regulation of estrogen sulfotransferase by estrogen in MCF-7 human mammary cancer cells.
Topics: Breast Neoplasms; Dactinomycin; Endometrium; Estradiol; Female; Humans; Receptors, Estrogen; Sulfotransferases; Sulfurtransferases; Tumor Cells, Cultured | 1992 |
[Leiomyosarcoma of the breast 16 years following successful treatment of a rhabdomyosarcoma of the orbit in childhood].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Child; Cyclophosphamide; Dactinomycin; Female; Humans; Leiomyosarcoma; Neoplasms, Second Primary; Rhabdomyosarcoma; Vincristine | 1992 |
Transcriptional regulation of prolactin receptor gene expression by sodium butyrate in MCF-7 human breast cancer cells.
Topics: Blotting, Northern; Breast Neoplasms; Butyrates; Butyric Acid; Cycloheximide; Dactinomycin; Gene Expression Regulation; Humans; Kinetics; Receptors, Prolactin; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured | 1992 |
[Use of thymoptin and chemotherapy in the complex treatment of breast cancer].
Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Neutrophils; Peptides; Phagocytosis; T-Lymphocytes; Thymosin; Thymus Extracts; Vincristine | 1991 |
Increased epidermal growth factor receptor gene expression by gamma-interferon in a human breast carcinoma cell line.
Topics: Breast Neoplasms; Cell Line; Cycloheximide; Dactinomycin; ErbB Receptors; Female; Gene Expression; Humans; Interferon-gamma; Kinetics; RNA, Messenger; Transcription, Genetic | 1991 |
Post-mastectomy lymphangiosarcoma (Stewart-Treves syndrome): report of two long-term survivals.
Topics: Aged; Breast Neoplasms; Combined Modality Therapy; Dactinomycin; Female; Humans; Lymphangiosarcoma; Lymphedema; Mastectomy; Neoplasms, Multiple Primary; Postoperative Complications; Radiotherapy, High-Energy; Soft Tissue Neoplasms; Syndrome | 1991 |
P-glycoprotein-independent mechanism of resistance to VP-16 in multidrug-resistant tumor cell lines: pharmacokinetic and photoaffinity labeling studies.
Topics: Affinity Labels; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Binding, Competitive; Breast Neoplasms; Cricetinae; Cricetulus; Dactinomycin; Doxorubicin; Drug Resistance; Etoposide; Humans; Membrane Glycoproteins; Neoplasm Proteins; Tumor Cells, Cultured; Verapamil; Vinblastine; Vindesine | 1990 |
Progestin stimulation of thymidine kinase in the human breast cancer cell line T47D.
Topics: Breast Neoplasms; Cell Division; Dactinomycin; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Mifepristone; Progestins; Promegestone; Thymidine Kinase; Time Factors; Tumor Cells, Cultured | 1991 |
Estrogenic and antiestrogenic down-regulation of estrogen receptor levels: evidence for two different mechanisms.
Topics: Breast Neoplasms; Dactinomycin; Down-Regulation; Estradiol; Estrogen Antagonists; Female; Humans; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured | 1990 |
Enhanced glycosyltransferase activity during thermotolerance development in mammalian cells.
Topics: Animals; Arsenic; Arsenites; beta-D-Galactoside alpha 2-6-Sialyltransferase; Breast Neoplasms; Cell Line; Cricetinae; Cycloheximide; Dactinomycin; Diamide; Fucosyltransferases; Galactoside 2-alpha-L-fucosyltransferase; Galactosyltransferases; Heat-Shock Proteins; Hot Temperature; Humans; Kinetics; N-Acetylgalactosaminyltransferases; Sialyltransferases; Sodium Compounds; Tumor Cells, Cultured | 1990 |
Nasopharyngeal rhabdomyosarcoma presenting as a breast mass.
Topics: Adolescent; Breast Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Nasopharyngeal Neoplasms; Rhabdomyosarcoma; Tomography, X-Ray Computed; Vincristine | 1990 |
Transcriptional regulation of DF3 gene expression in human MCF-7 breast carcinoma cells.
Topics: Antigens, Neoplasm; Blotting, Northern; Breast Neoplasms; Cycloheximide; Dactinomycin; Gene Expression Regulation; Glycoproteins; Humans; Molecular Weight; RNA, Messenger; RNA, Neoplasm; Tetradecanoylphorbol Acetate; Transcription, Genetic; Tumor Cells, Cultured | 1990 |
Tritiated actinomycin-D staining method: a valuable tool to study oestrogen receptor-induced modifications of transcriptional activity in normal and neoplastic cells.
Topics: Animals; Autoradiography; Breast Neoplasms; Cell Line; Cell Nucleus; Dactinomycin; Estradiol; Female; Humans; Mammary Neoplasms, Experimental; Mice; Microscopy, Electron; Rats; Rats, Inbred Strains; Receptors, Estrogen; Transcription, Genetic; Tritium; Uterus | 1985 |
Induction of manganese superoxide dismutase by tumor necrosis factor in human breast cancer MCF-7 cell line and its TNF-resistant variant.
Topics: Breast Neoplasms; Cell Division; Cycloheximide; Cytosol; Dactinomycin; Drug Resistance; Enzyme Induction; Humans; Interleukin-1; Kinetics; Manganese; Mitochondria; Mutation; Receptors, Cell Surface; Receptors, Tumor Necrosis Factor; Superoxide Dismutase; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1989 |
Progestin inhibition of progesterone receptor gene expression in human breast cancer cells.
Topics: Blotting, Northern; Breast Neoplasms; Cell Line; Dactinomycin; Down-Regulation; Electrophoresis, Agar Gel; Electrophoresis, Polyacrylamide Gel; Gene Expression; Humans; Pregnenediones; Progesterone Congeners; Receptors, Progesterone; RNA, Messenger; Transcription, Genetic | 1989 |
Hormonal regulation of synthesis and secretion of pS2 protein relevant to growth of human breast cancer cells (MCF-7).
Topics: Androgens; Breast Neoplasms; Cell Division; Cycloheximide; Dactinomycin; DNA, Neoplasm; Estrogens; Humans; In Vitro Techniques; Nafoxidine; Neoplasm Proteins; Progesterone; Proteins; Tamoxifen; Trefoil Factor-1; Tumor Cells, Cultured; Tumor Suppressor Proteins | 1989 |
[The effect of chemotherapy on survival time in advanced breast carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Carmustine; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Female; Fluorouracil; Humans; Neoplasm Metastasis; Postoperative Care; Prednisone; Retrospective Studies; Time Factors; Vincristine | 1989 |
Early estrogen-induced metabolic changes and their inhibition by actinomycin D and cycloheximide in human breast cancer cells: 31P and 13C NMR studies.
Topics: Breast Neoplasms; Carbon Isotopes; Cell Line; Clone Cells; Cycloheximide; Dactinomycin; Estradiol; Female; Glucose; Glutamates; Glycolysis; Humans; Lactates; Magnetic Resonance Spectroscopy; Phospholipids; Phosphorus; Tamoxifen; Tumor Cells, Cultured | 1989 |
Resistance to hydrogen peroxide associated with altered catalase mRNA stability in MCF7 breast cancer cells.
Topics: Actins; Breast Neoplasms; Catalase; Dactinomycin; Drug Resistance; Glutathione Peroxidase; Half-Life; Humans; Hydrogen Peroxide; RNA, Messenger; Superoxide Dismutase; Tumor Cells, Cultured | 1989 |
Intensive short-term chemotherapy in patients with advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dactinomycin; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Remission Induction; Vincristine | 1987 |
Regulation of the 1,25-dihydroxyvitamin D3 receptor by 1,25-dihydroxyvitamin D3 in intact human cancer cells.
Topics: Breast Neoplasms; Calcitriol; Cells, Cultured; Cycloheximide; Dactinomycin; Deoxyadenosines; Humans; Puromycin; Receptors, Calcitriol; Receptors, Steroid; Time Factors; Tritium | 1985 |
Mitoxantrone affects topoisomerase activities in human breast cancer cells.
Topics: Anthraquinones; Breast Neoplasms; Cell Line; Dactinomycin; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Doxorubicin; Enzyme Induction; Humans; Kinetics; Mitoxantrone; Puromycin; Topoisomerase II Inhibitors | 1986 |
Cytostatic and cytotoxic activity of tumor necrosis factor on human cancer cells.
Topics: Breast Neoplasms; Cell Division; Cell Line; Cell Survival; Colonic Neoplasms; Cycloheximide; Cytotoxins; Dactinomycin; Female; Glycoproteins; Humans; Interferon-gamma; Melanoma; Neoplasm Proteins; Receptors, Cell Surface; Receptors, Tumor Necrosis Factor; Recombinant Proteins; Tumor Necrosis Factor-alpha; Uterine Cervical Neoplasms | 1987 |
Transcriptional regulation of c-myc oncogene expression by estrogen in hormone-responsive human breast cancer cells.
Topics: Breast Neoplasms; Cycloheximide; Dactinomycin; DNA; Estradiol; Gene Expression Regulation; Half-Life; Humans; Nucleic Acid Hybridization; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-myc; RNA, Messenger; Tamoxifen; Transcription, Genetic; Tumor Cells, Cultured | 1988 |
The effect of prior adjuvant chemotherapy on survival in metastatic breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Receptors, Estrogen; Retrospective Studies; Tamoxifen; Vincristine | 1988 |
[A case report of angiosarcoma of the breast].
Topics: Adult; Breast Neoplasms; Combined Modality Therapy; Dactinomycin; Female; Hemangiosarcoma; Humans; Lupus Erythematosus, Systemic; Prednisolone | 1987 |
A preliminary analysis of combination therapy with vincristine, adriamycin, and prednimustine (VAP) in advanced breast cancer: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Evaluation; Female; Humans; Leukopenia; Middle Aged; Procarbazine; Vincristine | 1986 |
[Cytostatic polychemotherapy in the aged].
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Fluorouracil; Humans; Lymphoma; Male; Melphalan; Methotrexate; Middle Aged; Multiple Myeloma; Prednisolone; Prednisone; Procarbazine; Risk; Vincristine | 1985 |
[Chemotherapy of metastasizing breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dactinomycin; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Metastasis; Prognosis; Vincristine | 1985 |
Relationship between the expression of estrogen-regulated genes and estrogen-stimulated proliferation of MCF-7 mammary tumor cells.
Topics: Amanitins; Breast Neoplasms; Cell Division; Cells, Cultured; Cycloheximide; Dactinomycin; DNA, Neoplasm; Estradiol; Estrogens; Female; Genes; Humans; Kinetics; Neoplasm Proteins; RNA, Messenger; RNA, Neoplasm; Tetrahydrofolate Dehydrogenase; Thymidine Kinase | 1985 |
[Mandatory surgery after failure of actinotherapy for malignant breast tumors].
Topics: Breast Neoplasms; Dactinomycin; Female; Humans; Mastectomy; Methods | 1969 |
[Cytostatic therapy causing the loss of serological activity in thrombocytes].
Topics: ABO Blood-Group System; Absorption; Adenocarcinoma; Antineoplastic Agents; Blood Platelets; Breast Neoplasms; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Dysgerminoma; Erythrocytes; Female; Hemagglutination Tests; Humans; Immune Sera; Isoantigens; Leukemia; Leukocytes; Male; Mercaptopurine; Methotrexate; Nitrogen Mustard Compounds; Pregnancy; Uracil Mustard | 1970 |
Restoration of several morphological characteristics of normal fibroblasts in sarcoma cells treated with adenosine-3':5'-cyclic monphosphate and its derivatives.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Animals; Breast Neoplasms; Butyrates; Cell Line; Choriocarcinoma; Cyclic AMP; Cycloheximide; Dactinomycin; Female; Pregnancy | 1971 |
Growth inhibiting effects of cytotoxic agents on human tumor and tumor-bearing normal tissue in vitro.
Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Papillary; Cyclophosphamide; Dactinomycin; Female; Fluorouracil; Humans; In Vitro Techniques; Middle Aged; Nucleic Acids; Phosphorus Isotopes; Stomach Neoplasms; Thiotepa; Vincristine | 1971 |
Sequential liver scanning.
Topics: Adult; Breast Neoplasms; Chloroquine; Colonic Neoplasms; Dactinomycin; Emetine; Estrogens; Female; Fluorouracil; Gold Colloid, Radioactive; Humans; Liver Abscess, Amebic; Liver Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Radionuclide Imaging; Thiotepa | 1969 |
Comments on morbidity in present-day radiotherapy.
Topics: Breast Neoplasms; Buttocks; Carcinoma, Squamous Cell; Dactinomycin; Erythema; Female; Fluorouracil; Hodgkin Disease; Humans; Laryngeal Neoplasms; Liver Cirrhosis; Methotrexate; Morbidity; Myelitis; Pharyngeal Neoplasms; Radiotherapy; Radiotherapy Dosage; Spinal Cord; Uterine Cervical Neoplasms; Xerostomia | 1971 |
Multiple drug therapy for disseminated malignant tumours.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Child; Cyclophosphamide; Cytarabine; Dactinomycin; Drug Synergism; Female; Fluorouracil; Humans; Leukocyte Count; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasms; Remission, Spontaneous; Urinary Bladder Neoplasms; Vincristine | 1971 |
Combined chemotherapy of epithelial tumours.
Topics: Breast Neoplasms; Cobalt Isotopes; Cyclophosphamide; Dactinomycin; DNA, Neoplasm; Female; Humans; Male; Mercaptopurine; Methotrexate; Neoplasm Metastasis; Neoplasms; Prednisone; Radiotherapy Dosage; RNA, Messenger; Testicular Neoplasms | 1970 |
Clinical immunologic responsiveness in malignant disease. I. Delayed hypersensitivity reaction and the effect of cytotoxic drugs.
Topics: Adolescent; Adult; Aged; Antigens; Antineoplastic Agents; Breast Neoplasms; Candida; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Hypersensitivity, Delayed; Immunosuppressive Agents; Leukopenia; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mumps virus; Neoplasms; Nitrobenzenes; Ovarian Neoplasms; Skin Tests; Tuberculin; Uterine Cervical Neoplasms; Vinblastine | 1970 |
Hypercalcemia associated with neoplastic disease.
Topics: Breast Neoplasms; Bronchial Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Dactinomycin; Electrocardiography; Female; Humans; Hypercalcemia; Leukemia; Lung Neoplasms; Lymphoma; Male; Middle Aged; Multiple Myeloma; Neoplasms; Prednisone | 1970 |
Chemotherapy of solid tumors.
Topics: Age Factors; Alkylating Agents; Antimetabolites; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Dactinomycin; Female; Hormones; Humans; Neoplasms; Vinblastine; Vincristine | 1970 |
Combined actinomycin D and vincristine in the treatment of patients with cancer.
Topics: Breast Neoplasms; Dactinomycin; Humans; Lung Neoplasms; Melanoma; Neoplasms; Sarcoma; Vincristine | 1971 |